Risk factors analysis for Pneumocystis jiroveci pneumonia (PCP) in patients with haematological malignancies and pneumonia (Q36211354)

6 February 2018

title

Risk factors analysis for Pneumocystis jiroveci pneumonia (PCP) in patients with haematological malignancies and pneumonia (English)

1 reference

6 February 2018

0 references

France Roblot

1

0 references

Cendrine Godet

3

object named as

Cendrine Godet

1 reference

6 February 2018

Pascal Roblot

7

object named as

Pascal Roblot

1 reference

6 February 2018

Bertrand Becq-Giraudon

10

object named as

Bertrand Becq-Giraudon

1 reference

6 February 2018

author name string

Sabrina Imbert

2

1 reference

6 February 2018

Catherine Kauffmann

4

1 reference

6 February 2018

Stephanie Ragot

5

1 reference

6 February 2018

Gwenael Le Moal

6

1 reference

6 February 2018

Marie Helene Rodier

8

1 reference

6 February 2018

Rene Robert

9

1 reference

6 February 2018

Francois Guilhot

11

1 reference

6 February 2018

publication date

1 January 2004

1 reference

6 February 2018

Scandinavian Journal of Infectious Diseases

published in

1 reference

6 February 2018

volume

36

1 reference

6 February 2018

issue

11-12

1 reference

6 February 2018

page(s)

848-854

1 reference

6 February 2018

Analysis of underlying diseases and prognosis factors associated with Pneumocystis carinii pneumonia in immunocompromised HIV-negative patients

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00365540410021180

Summary of the Guidelines for Preventing Opportunistic Infections among Hematopoietic Stem Cell Transplant Recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540410021180

Pneumocystis carinii pneumonia in patients with malignant haematological diseases: 10 years' experience of infection in GIMEMA centres.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540410021180

Cost-effectiveness of prophylaxis against Pneumocystis carinii pneumonia in patients with Wegner's granulomatosis undergoing immunosuppressive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540410021180

Opportunistic infections in patients with and patients without Acquired Immunodeficiency Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540410021180

Pneumocystis carinii pneumonia in patients with hematologic malignancies: a descriptive study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540410021180

The impact of novel immunosuppressive agents on infections in organ transplant recipients and the interactions of these agents with antimicrobials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540410021180

Pneumocystis carinii pneumonia prophylaxis in HIV negative patients with primary CNS lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540410021180

Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540410021180

Pneumocystis carinii pneumonia associated with weekly methotrexate: cumulative dose of methotrexate and low CD4 cell count may predict this complication

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540410021180

Alemtuzumab in previously treated chronic lymphocytic leukemia patients who also had received fludarabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540410021180

Frequency and type of serious infections in fludarabine-refractory B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma: implications for clinical trials in this patient population

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540410021180

Pneumocystis carinii pneumonia as a complication of methotrexate treatment of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540410021180

Fludarabine and mitoxantrone: effective and well-tolerated salvage therapy in relapsed indolent lymphoproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540410021180

Prognostic markers of short-term mortality in AIDS-associated Pneumocystis carinii pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540410021180

Pneumocystis carinii pneumonia in critically ill patients with malignancy: a descriptive study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540410021180

Management and outcome patterns for adult Pneumocystis carinii pneumonia, 1985 to 1995: comparison of HIV-associated cases to other immunocompromised states

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540410021180

10.1080/00365540410021180

21 January 2018

Identifiers

DOI

1 reference

6 February 2018

PubMed ID

15764172

1 reference

6 February 2018